Fortis Healthcare’s subsidiary -- Fortis Healthcare Singapore -- is reportedly planning to divest its entire stake in diagnostic and molecular imaging unit RadLink-Asia. Malaysia’s IHH Healthcare Bhd, Asia’s largest hospital operator by stock market value, will buy the assets for 137 million Singaporean dollars (around $108.5 million).
The deal will be successfully closed following the necessary statutory and regulatory approvals as per local requirements. J P Morgan and Religare Capital Markets acted as financial advisors to Fortis for this transaction.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 9 countries.
